EUVIMEDEUVIMED entdecken
Crossref

Preconception Hydroxychloroquine Therapy Restores Placental Function and Improves Pregnancy Outcomes in Obstetric Antiphospholipid Syndrome

Yanjun Cai, Mingjie Song, Qingfeng Lv, Hongli Liu, Yuan Wang, Weiyi Qi, Die Jing, Yu Xia, Xietong Wang

Antioxidants & Redox Signaling · 2026

DOI: 10.1177/15230864261424203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2026. Verfasst von Yanjun Cai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong First Medical University, Jinan City, China. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Hydroxychloroquine, Placenta, Pregnancy Complications. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Obstetric antiphospholipid syndrome (OAPS), a representative autoimmune disorder driven by antiphospholipid antibodies (aPLs), afflicts 30% of patients with refractory to conventional antithrombotic treatment. Hydroxychloroquine (HCQ) offers adjunctive potential, yet its mechanistic action and critical treatment timing remain undefined. This study establishes the preventive efficacy of preconception HCQ initiation (HCQ-pre) and deciphers its fundamental rescue pathways in OAPS.

Results

Clinical data suggested a potential advantage of HCQ-pre compared to post-conception administration (HCQ-post) in optimizing pregnancy outcomes for patients with OAPS. Modeling the pathology of OAPS using human trophoblast organoids revealed that HCQ-pre effectively reverses aPLs-mediated trophoblast dysfunction: increasing cytotrophoblast proliferation (Ki67 + /TP63 + ) by 20% and restoring their differentiation into extravillous trophoblast (HLA-G + ) to 93% of control levels, while HCQ-post shows markedly limited efficacy. Mechanistically, HCQ-pre preemptively corrected aPLs-induced redox imbalance by rescuing hypoxia-inducible factor 1-alpha-mediated hypoxia and replenishing antioxidant mediators (NRF2/SOD2/GPX4) via Hippo/YAP and Wnt/β-catenin signaling. Murine OAPS models established that HCQ-pre restores placental perfusion (90% of control levels) by enhancing spiral artery remodeling—with diminished efficacy observed at post-conception administration—thereby attenuating hypoperfusion-induced hypoxic damage and improving pregnancy outcomes. Innovation and Conclusions: We redefine HCQ as a proactive placental resetter that neutralizes oxidative stress barriers preconception, thereby liberating trophoblast differentiation capacity. This work positions HCQ-pre as the critical intervention phase—a paradigm shift from reactive adjunct to preemptive root-cause interception, providing the mechanistic foundation for optimizing OAPS management through timely individualized prophylaxis. Antioxid. Redox Signal. 00, 000–000.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeHydroxychloroquinePlacentaPregnancy ComplicationsFemalePregnancyHumansAnimalsPregnancy OutcomeTrophoblastsMiceAntibodies, Antiphospholipid

Stichwörter der Autor:innen

hydroxychloroquineobstetric antiphospholipid syndromeorganoidspreconception therapypregnancy outcomesredox imbalancetrophoblast differentiation

Substanzen

HydroxychloroquineAntibodies, Antiphospholipid

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong First Medical University, Jinan City, China.
  • Medical Science and Technology Innovation Center (Institute of Translational Medicine), Shandong First Medical University, Jinan City, China.
  • Department of Obstetrics and Gynecology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai City, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cai, Y., Song, M., Lv, Q., Liu, H., Wang, Y., Qi, W., Jing, D., Xia, Y., & Wang, X. (2026). Preconception Hydroxychloroquine Therapy Restores Placental Function and Improves Pregnancy Outcomes in Obstetric Antiphospholipid Syndrome. Antioxidants & Redox Signaling. https://doi.org/10.1177/15230864261424203

Vancouver

Cai Y, Song M, Lv Q, Liu H, Wang Y, Qi W, et al. Preconception Hydroxychloroquine Therapy Restores Placental Function and Improves Pregnancy Outcomes in Obstetric Antiphospholipid Syndrome. Antioxidants & Redox Signaling. 2026. doi:10.1177/15230864261424203

BibTeX
@article{Cai2026,
  author = {Cai, Yanjun and Song, Mingjie and Lv, Qingfeng and Liu, Hongli and Wang, Yuan and Qi, Weiyi and Jing, Die and Xia, Yu and Wang, Xietong},
  title = {Preconception Hydroxychloroquine Therapy Restores Placental Function and Improves Pregnancy Outcomes in Obstetric Antiphospholipid Syndrome},
  journal = {Antioxidants & Redox Signaling},
  year = {2026},
  doi = {10.1177/15230864261424203}
}
Kostenlos starten →